OpenVSafe by OpenVAERS
Search V-safe

WV5-25070-18951

3 vaccinations 2 coded responses 6 check-ins 1 free-text entry 2 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
598 / MT
Registered
2022-06-22
Relationship
Child or adolescent in my care
Guardian
FXN-10924-62097
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-22
    Registered in v-safe
  2. 2022-09-07
    Dose 1 — Pfizer-BioNTech
  3. 2022-10-03
    Dose 2 — Pfizer-BioNTech
  4. 2022-11-29
    Dose 3 — Pfizer-BioNTech
  5. 2022-12-19
    Survey response — day 14, dose 3, under 3
    MedDRA: Cough, Increased viscosity of upper respiratory secretion, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Croup cough, thick nasal drainage.
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-12-19
    Report sent to call center — day 14, dose 3, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  7. 2022-12-20
  8. 2022-12-23
    Health check-in — day 21, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  9. 2022-12-29
    Health check-in — day 28, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  10. 2023-01-11
    Health check-in — day 42, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  11. 2023-02-28
    Health check-in — 3 months, dose 3, under 3
    Feeling: Good
    Under 3 check-in
  12. 2023-06-01
    Survey response — 6 months, dose 3, under 3
    MedDRA: Norovirus infection, Unevaluable event — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  13. 2023-06-01
  14. 2023-06-02
  15. 2023-06-02

Vaccinations

DoseDateManufacturerCo-administered
12022-09-07Pfizer-BioNTech No
22022-10-03Pfizer-BioNTech No
32022-11-29Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — day 14, dose 3, under 3

2022-12-19

Symptoms: Croup cough, thick nasal drainage.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDIncreased viscosity of upper respiratory secretion · · ✓
SDNorovirus infection · · ✓
SDRhinorrhoea · · ✓
SDUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release